Research Paper Volume 8, Issue 4 pp 751—768
Perlecan expression influences the keratin 15‐positive cell population fate in the epidermis of aging skin
- 1 Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, UMR 5305, CNRS, University Lyon 1, Lyon, France
- 2 BASF BCS France SAS, 69366, Lyon, France
- 3 Graduate School of Biomedical Engineering, University of New South Wales Sydney, Australia
- 4 Cell and Tissue Bank, Hôpital Edouard Herriot, Lyon, France
Received: January 13, 2016 Accepted: February 23, 2016 Published: March 17, 2016
https://doi.org/10.18632/aging.100928How to Cite
Abstract
The epidermis is continuously renewed by stem cell proliferation and differentiation. Basal keratinocytes append the dermal‐epidermal junction, a cell surface‐associated, extracellular matrix that provides structural support and influences their behaviour. It consists of laminins, type IV collagen, nidogens, and perlecan, which are necessary for tissue organization and structural integrity. Perlecan is a heparan sulfate proteoglycan known to be involved in keratinocyte survival and differentiation. Aging affects the dermal epidermal junction resulting in decreased contact with keratinocytes, thus impacting epidermal renewal and homeostasis. We found that perlecan expression decreased during chronological skin aging. Our in vitro studies revealed reduced perlecan transcript levels in aged keratinocytes. The production of in vitro skin models revealed that aged keratinocytes formed a thin and poorly organized epidermis. Supplementing these models with purified perlecan reversed the phenomenon allowing restoration of a well‐differentiated multi‐layered epithelium. Perlecan down‐regulation in cultured keratinocytes caused depletion of the cell population that expressed keratin 15. This phenomenon depended on the perlecan heparan sulphate moieties, which suggested the involvement of a growth factor. Finally, we found defects in keratin 15 expression in the epidermis of aging skin. This study highlighted a new role for perlecan in maintaining the self‐renewal capacity of basal keratinocytes.
Abbreviations
DEJ: dermal-epidermal junction; ECM: dermalextracellular matrix; BM: basement membrane; HSPG: heparan sulfate proteoglycan; NHK: normal human keratinocytes; SE: skin equivalent; DE: dermal equivalent.